DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Monomethyl auristatin F
Monomethyl auristatin F
Seattle Genetics and Genmab Enter Into New Antibody-Drug Conjugate Collaboration
Homogeneous Antibody-Drug Conjugates Via Site-Selective Disulfide Bridging
Antibody–Drug Conjugates: the Last Decade
Targeting and Efficacy of Novel Mab806-Antibody-Drug Conjugates in Malignant Mesothelioma
Adcetris, INN-Brentuximab Vedotin
Peptide-Drug Conjugate for Her2-Targeted Drug Delivery Yan Wang University of the Pacific,
[email protected]
PDF of Antibody News
Characterization of ABBV-221, a Tumor-Selective EGFR Targeting Antibody Drug Conjugate
Marine Anticancer Agents: an Overview with a Particular Focus on Their Chemical Classes
349 a AAC, See Antibody-Antibiotic Conjugate Acid-Labile Linkers, 51, 59
Resistance to Antibody–Drug Conjugates Sara García-Alonso1, Alberto Ocana~ 2, and Atanasio Pandiella1
(12) Patent Application Publication (10) Pub. No.: US 2016/0122430 A1 Gish Et Al
Current Status: Site-Specific Antibody Drug Conjugates
Targeting Multiple EGFR Expressing Tumors with a Highly Potent Tumor-Selective Antibody
Precision Chemo-Radiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability
Antibody-Drug Conjugates: the New Frontier of Chemotherapy
XTEN CONJUGATE COMPOSITIONS and Filed on Jun
Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
Top View
Monomethyl Auristatin E-Conjugated Anti-EGFR Antibody Inhibits The
Blenrep; INN-Belantamab Mafodotin
WO 2017/133745 Al 10 August 2017 (10.08.2017) P O PCT